ICEQX | VTSMX | ICEQX / VTSMX | |
Total Expense Ratio | 0.67 | 0.14 | 479% |
Annual Report Gross Expense Ratio | 0.70 | 0.14 | 500% |
Fund Existence | 11 years | 33 years | - |
Gain YTD | 3.346 | 1.349 | 248% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.77B | 1.82T | 0% |
Annual Yield % from dividends | 0.33 | 1.18 | 28% |
Returns for 1 year | 2.35 | 10.06 | 23% |
Returns for 3 years | 26.20 | 57.59 | 45% |
Returns for 5 years | 43.41 | 91.36 | 48% |
Returns for 10 years | 46.30 | 178.92 | 26% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTDZX | 124.83 | -0.64 | -0.51% |
Franklin Biotechnology Discovery Adv | |||
SAOIX | 30.12 | -0.19 | -0.63% |
NAA Opportunity Fund Institutional | |||
LMESX | 35.64 | -0.37 | -1.03% |
ClearBridge Appreciation IS | |||
OALGX | 20.72 | -0.28 | -1.33% |
Optimum Large Cap Growth A | |||
GGEAX | 22.73 | -0.33 | -1.43% |
Nationwide Global Sust Eq A |